Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 43 CNY -4.04%
Market Cap: 5.1B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Acrobiosystems Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acrobiosystems Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
Accounts Receivables
ÂĄ74.3m
CAGR 3-Years
33%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Accounts Receivables
ÂĄ2.5B
CAGR 3-Years
86%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Accounts Receivables
ÂĄ271m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accounts Receivables
ÂĄ3B
CAGR 3-Years
63%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Accounts Receivables
ÂĄ949.9m
CAGR 3-Years
26%
CAGR 5-Years
3%
CAGR 10-Years
25%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accounts Receivables
ÂĄ25.5B
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
50%
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
5.1B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
48.56 CNY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's Accounts Receivables?
Accounts Receivables
74.3m CNY

Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's Accounts Receivables amounts to 74.3m CNY.

What is Acrobiosystems Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
52%

Over the last year, the Accounts Receivables growth was 20%. The average annual Accounts Receivables growth rates for Acrobiosystems Co Ltd have been 33% over the past three years , 52% over the past five years .

Back to Top